U.S. commercial launch
-
Biologics
Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM
BIOINCYTE™ is a Next-Generation Autologous Fibrin and Platelet System HACKENSACK, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) — Royal Biologics, a…
Read More » -
Biologics
Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System
June 1, 2022 – OrthoSpineNews – Royal Biologics (Hackensack, NJ) a company specializing on Advanced Cellular Technologies & Enhanced Autologous…
Read More » -
Spine
NuVasive Launches First-Of-Its-Kind Brigade® Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery
SAN DIEGO, Nov. 15, 2018 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
K2M Announces US Launch of First-to-Market 3D-Printed Expandable Interbody MOJAVE™ PL 3D Expandable Featuring Lamellar 3D Titanium Technology™
LEESBURG, Va., May 16, 2018 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex…
Read More » -
Hospitals
SI-BONE Wins FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D Implant
SAN JOSE, Calif., June 13, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More »